ethyl-isobutyl-malonic acid | 4473-06-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: ethyl-isobutyl-malonic acid
• 英文别名: Aethyl-isobutyl-malonsaeure；2-Ethyl-2-(2-methylpropyl)propanedioic acid
• CAS: 4473-06-7
• 化学式: C₉H₁₆O₄
• 分子量: 188.224
• InChiKey: VTCLYUQZJWJNRR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  74.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  ethyl-isobutyl-malonic acid 生成 3-ethyl-4-methylpentanoic acid
  参考文献：
  名称：

  Tiffeneau, Bulletin de la Societe Chimique de France, 1923, vol. <4> 33, p. 186

  摘要：

  DOI：
• 作为产物：
  描述：

  ethyl-isobutyl-malonic acid diethyl ester 在 氢氧化钾 作用下， 生成 ethyl-isobutyl-malonic acid
  参考文献：
  名称：

  Tiffeneau, Bulletin de la Societe Chimique de France, 1923, vol. <4> 33, p. 186

  摘要：

  DOI：

文献信息

• [EN] CASPASE INHIBITORS CONTAINING DICARBONYLAMINO-ISOXAZOLINE<br/>[FR] INHIBITEURS DE CASPASE CONTENANT DICARBONYLAMINO-ISOXAZOLINE
  申请人：LG LIFE SCIENCES LTD

  公开号：WO2006033551A1

  公开（公告）日：2006-03-30

  The present invention relates to a dicarbonylamino-isoxazoline derivative as an inhibitor against various caspases and a therapeutic composition for preventing inflammation and apoptosis comprising the same.

  本发明涉及一种二羰基氨基异噁唑啉衍生物，作为对抗各种半胱氨酸蛋白酶的抑制剂，以及包含该衍生物的用于预防炎症和细胞凋亡的治疗组合物。
• Caspase inhibitors containing isoxazoline ring
  申请人：Chang Hye-Kyung

  公开号：US20060223848A1

  公开（公告）日：2006-10-05

  The present invention relates to an isoxazoline derivative as an inhibitor against various caspases, a process for preparing the same, and a therapeutic composition for preventing inflammation and apoptosis comprising the same

  本发明涉及一种异噁唑啉衍生物作为对各种半胱天冬氨酸蛋白酶的抑制剂，其制备方法，以及包含该异噁唑啉衍生物的治疗组合物，用于预防炎症和细胞凋亡。
• Further Branching of Valproate-Related Carboxylic Acids Reduces the Teratogenic Activity, but Not the Anticonvulsant Effect
  作者：Ursula Bojic、Mohamed M. A. Elmazar、Ralf-Siegbert Hauck、Heinz Nau

  DOI：10.1021/tx950216s

  日期：1996.1.1

  In the present study, compounds derived from the anticonvulsant drug valproic acid (VPA, 2-n-propylpentanoic acid) and analogues known to be teratogenic were synthesized with an additional carbon-branching in one of the side chains. The substances were tested for their ability to induce anticonvulsant-activity and sedation in adult mice, and neural tube defects (exencephaly) in the offspring of pregnant animals (Han:NMRI mice). In all cases, the rates of exencephaly, embryolethality, and fetal weight retardation induced by the methyl-branched derivatives were very low when compared to those of the parent compounds, These novel compounds exhibited anticonvulsant activity which was not significantly different from that of VPA. Neurotoxicity was considerably lower for some compounds as compared to VPA. Anticonvulsant activity and neurotoxicity of branched short chain fatty acids are far less structure-dependent and not related to teratogenic potency. Within this series of compounds, (+/-)-4-methyl-2-n-propyl-4-pentenoic acid and (+/-)-2-isobutyl-4-pentenoic acid exhibited the most favorable profile in regard to high anticonvulsant effect, low sedation, and teratogenicity. Valproic acid analogues with additional methyl branching may be valuable antiepileptic agents with low teratogenic potential.
• CASPASE INHIBITORS CONTAINING ISOXAZOLINE RING
  申请人：LG Life Sciences Ltd.

  公开号：EP1660464B1

  公开（公告）日：2015-02-25
• US4540781A
  申请人：——

  公开号：US4540781A

  公开（公告）日：1985-09-10